KDM4C and glioblastoma: The above data were also confirmed by the treatment of SD70 in the glioblastoma cells (Fig. S4A), wherein KDM4C inhibition decreased the growth and viability of various glioblastoma cells both time- and dose-dependently (Fig. S4C, D and Fig. S6).